Achyut Healthcare Ltd Stock Price Today (NSE: ACHYUT)
Fundamental Score
Achyut Healthcare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Achyut Healthcare Ltd share price today is ₹7.10, up +4.11% on NSE/BSE as of 7 August 2026. Achyut Healthcare Ltd (ACHYUT) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹180.78 (Cr). The 52-week high for ACHYUT share price is ₹10.04 and the 52-week low is ₹4.03. At a P/E ratio of 564.93x, ACHYUT is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 0.96% and a debt-to-equity ratio of 0.01.
Achyut Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Achyut Healthcare Ltd share price chart: -19.90% return over the past month. 52-week high ₹10.04, 52-week low ₹4.03.
Achyut Healthcare Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹7.18 | ₹7.37 | ₹6.73 | ₹6.82 | 28.62K (Cr) | |
| ₹7.40 | ₹7.42 | ₹6.82 | ₹7.07 | 88.76K (Cr) | |
| ₹7.10 | ₹7.14 | ₹6.52 | ₹7.07 | 97.47K (Cr) | |
| ₹6.48 | ₹6.80 | ₹6.48 | ₹6.80 | 1.10L (Cr) | |
| ₹6.51 | ₹6.86 | ₹6.42 | ₹6.48 | 21.44K (Cr) | |
| ₹7.00 | ₹7.01 | ₹6.60 | ₹6.63 | 24.63K (Cr) | |
| ₹6.96 | ₹7.20 | ₹6.52 | ₹6.91 | 62.28K (Cr) | |
| ₹6.95 | ₹7.05 | ₹6.44 | ₹6.86 | 61.84K (Cr) | |
| ₹7.27 | ₹7.27 | ₹6.72 | ₹6.74 | 1.14L (Cr) | |
| ₹7.25 | ₹7.25 | ₹6.94 | ₹7.07 | 59.57K (Cr) |
Achyut Healthcare Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹6.48 | ₹7.42 | ₹6.48 | ₹6.82 | +5.25% | |
| ₹8.09 | ₹8.84 | ₹6.42 | ₹6.48 | -19.90% | |
| ₹5.75 | ₹10.04 | ₹5.55 | ₹7.73 | +34.43% | |
| ₹5.48 | ₹6.05 | ₹4.70 | ₹5.77 | +5.29% | |
| ₹5.62 | ₹5.95 | ₹5.12 | ₹5.27 | -6.23% | |
| ₹5.30 | ₹5.99 | ₹4.87 | ₹5.27 | -0.57% | |
| ₹5.40 | ₹6.80 | ₹5.00 | ₹5.28 | -2.22% | |
| ₹5.54 | ₹5.97 | ₹5.00 | ₹5.07 | -8.48% | |
| ₹5.93 | ₹6.10 | ₹4.91 | ₹5.50 | -7.25% | |
| ₹5.53 | ₹5.98 | ₹4.98 | ₹5.84 | +5.61% | |
| ₹6.05 | ₹6.05 | ₹5.82 | ₹5.82 | -3.80% | |
| ₹5.24 | ₹6.57 | ₹4.90 | ₹6.17 | +17.75% |
AI Research Briefing
Powered by Gemini · 2026-04-17
Micro-cap pharma lottery ticket with a broken business model and insane valuation.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search.
CORE STORY (THE REAL GAME)
Micro-cap pharma play trading on hopes of a turnaround, fueled by aggressive 5Y sales CAGR of 56.01%. The market is betting on Achyut transitioning from a low-profitability trader to a high-growth manufacturer.
- Promoter buying
- Insider activity
- Sector tailwinds from India Pharma 2026
- Successful transition to manufacturing
- Significant order wins
- Improved profitability
- Micro/SME cap liquidity risk
- Negative free cash flow
- Extremely high P/E ratio
- Low ROE
- Decreasing promoter holding over last 3 years
Promoter increased stake by 0.69%, FII decreased stake by -0.88%.
India Pharma 2026 highlights a policy push and innovation driving sectoral growth.
Achyut Healthcare Limited announced that it has received INR 34.8 million in funding on March 22, 2026.
No. Free Cash Flow 5Y: ₹-32.02 Cr
The next 3-6 months will be crucial to see if the company can improve profitability and justify its valuation. Without significant improvements, the stock is likely to underperform.
Primary Thesis Risk
Inability to convert sales growth into sustainable profits.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Achyut Healthcare Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Achyut Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ACHYUT across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Revenue Growth (377.17%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (112.10% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (100.00% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (10.25x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (0.96%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (1.23%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-1.13%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 564.93x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-50.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-4.47% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-39.18 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 5.13%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Achyut Healthcare Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Achyut Healthcare Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Achyut Healthcare LtdAchyut Healthca...Selected✓ ACHYUT • 543499 | 39.8/100 | ₹7.10₹7 | ₹180.78₹180.78 | 564.93Average 564.9 Average | 0.96%Poor 0.96% Poor | 1.23%Poor 1.23% Poor | 0.01Excellent 0.0 Excellent | 100.00%Excellent 100.00% Excellent | 112.10%Excellent 112.10% Excellent | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
Achyut Healthcare Ltd PE Ratio History
Historical price-to-earnings ratio for ACHYUT — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.02 | ₹3.96 | 198x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Achyut Healthcare Ltd Quarterly Performance
Latest quarterly metrics for ACHYUT — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
377.17%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-50.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
112.10%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
100.00%
Compounded annual net profit growth over 5 years
Achyut Healthcare Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ACHYUT — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Achyut Healthcare Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Achyut Healthcare Ltd (ACHYUT) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Achyut Healthcare Ltd
About ACHYUT (Achyut Healthcare Ltd)
Achyut Healthcare Ltd is a dynamic pharmaceutical company committed to delivering innovative healthcare solutions across India and beyond. From its state-of-the-art manufacturing f...acilities, Achyut formulates and distributes a diverse range of pharmaceutical products, meticulously crafted to meet the evolving needs of patients and healthcare professionals. The company’s portfolio encompasses a broad spectrum of therapeutic areas, featuring high-quality tablets, capsules, syrups, and injectable medications. A steadfast dedication to research and development allows Achyut to continuously expand its product offerings and improve existing treatments, ensuring patients have access to the most effective and advanced therapies available. Driven by a culture of excellence and integrity, Achyut strives to improve the health and well-being of communities it serves. At the heart of Achyut Healthcare’s operations is an unwavering commitment to quality and compliance. The company adheres to the strictest international standards in pharmaceutical manufacturing, ensuring that every product meets the highest benchmarks of safety, efficacy, and purity. Achyut's robust quality control systems encompass every stage of the production process, from sourcing raw materials to packaging and distribution. This dedication to quality extends beyond the manufacturing floor, encompassing a comprehensive approach to ethical business practices, environmental stewardship, and employee well-being. Achyut believes that by prioritizing quality in every aspect of its operations, it can build trust with patients, healthcare providers, and stakeholders alike. Headquartered in Ahmedabad, India, Achyut Healthcare leverages its strategic location and experienced workforce to efficiently serve a vast and growing market. With a strong domestic presence, Achyut also focuses on expanding its global footprint through strategic partnerships and export initiatives. The company’s commitment to innovation, quality, and accessibility has earned it a reputation as a reliable and trusted provider of pharmaceutical products. Achyut's vision is to be a leading force in the pharmaceutical industry, contributing to improved health outcomes and a better quality of life for people around the world. The company continues to invest in research, development, and infrastructure to achieve its mission and solidify its position as a leading healthcare provider.
Company Details
Key Leadership
Latest News
ACHYUT Share Price: Frequently Asked Questions
What is the current share price of Achyut Healthcare Ltd?
Achyut Healthcare Ltd (ACHYUT) trades at ₹7.10 on NSE and BSE. Market cap ₹180.78 (Cr). Educational data only.
What is the P/E ratio of Achyut Healthcare Ltd?
Achyut Healthcare Ltd has a P/E of 564.93x vs industry average 34.89x.
What is the Bull Run score for Achyut Healthcare Ltd?
Achyut Healthcare Ltd has a Bull Run score of 39.8/100 based on 25+ financial parameters.
Does Achyut Healthcare Ltd pay dividends?
Achyut Healthcare Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Achyut Healthcare Ltd?
Achyut Healthcare Ltd has ROE of 0.96%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Achyut Healthcare Ltd?
Achyut Healthcare Ltd has debt-to-equity of 0.01.
Is Achyut Healthcare Ltd a good investment?
Bull Run gives Achyut Healthcare Ltd a score of 39.8/100. This is not investment advice — consult a SEBI-registered advisor.